Glucocorticoid Effects on Adiponectin Expression

Vitamins and Hormones

Volumn 90, Issue , 2012, Pages 163-186

  Sukumaran, Siddharth ^a   DuBois, Debra C ^a   Jusko, William J ^a   Almon, Richard R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Adiponectin; Diabetes; Gene expression; Glucocorticoids; Insulin; Obesity; Time series experiments

Indexed keywords

EID: 84866607442     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398313-8.00007-5     Document Type: Chapter

References (75)

1. Almon R.R., DuBois D.C., Jusko W.J. A microarray analysis of the temporal response of liver to methylprednisolone: A comparative analysis of two dosing regimens. Endocrinology 2007, 148:2209-2225.
2. Almon R.R., DuBois D.C., Pearson K.E., Stephan D.A., Jusko W.J. Gene arrays and temporal patterns of drug response: Corticosteroid effects on rat liver. Functional & Integrative Genomics 2003, 3:171-179.
3. Almon R.R., DuBois D.C., Piel W.H., Jusko W.J. The genomic response of skeletal muscle to methylprednisolone using microarrays: Tailoring data mining to the structure of the pharmacogenomic time series. Pharmacogenomics 2004, 5:525-552.
4. Almon R.R., DuBois D.C., Yao Z., Hoffman E.P., Ghimbovschi S., Jusko W.J. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: Comparative analysis of two dosing regimens. Physiological Genomics 2007, 30:282-299.
5. Almon R.R., Lai W., DuBois D.C., Jusko W.J. Corticosteroid-regulated genes in rat kidney: Mining time series array data. American Journal of Physiology. Endocrinology and Metabolism 2005, 289:E870-E882.
6. Andrews R.C., Walker B.R. Glucocorticoids and insulin resistance: Old hormones, new targets. Clinical Science (London, England) 1999, 96:513-523.
7. Barnes P.J. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clinical Science (London, England) 1998, 94:557-572.
8. Besser G.M., Jeffcoate W.J. Endocrine and metabolic diseases. Adrenal diseases. British Medical Journal 1976, 1:448-451.
9. Bjorndal B., Burri L., Staalesen V., Skorve J., Berge R.K. Different adipose depots: Their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. Journal of Obesity 2011, 2011:490650.
10. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Developmental Cell 2002, 3:25-38.
11. Brame L.A., Considine R.V., Yamauchi M., Baron A.D., Mather K.J. Insulin and endothelin in the acute regulation of adiponectin in vivo in humans. Obesity Research 2005, 13:582-588.
12. Cimmino M.A., Andraghetti G., Briatore L., Salani B., Parodi M., Cutolo M., et al. Changes in adiponectin and leptin concentrations during glucocorticoid treatment: A pilot study in patients with polymyalgia rheumatica. Annals of the New York Academy of Sciences 2010, 1193:160-163.
13. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003, 52:268-276.
14. Darmon P., Dadoun F., Boullu-Ciocca S., Grino M., Alessi M.C., Dutour A. Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity. American Journal of Physiology. Endocrinology and Metabolism 2006, 291:E995-E1002.
15. de Oliveira C., de Mattos A.B., Biz C., Oyama L.M., Ribeiro E.B., do Nascimento C.M. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations. Lipids in Health and Disease 2011, 10:11.
16. de Oliveira C., Iwanaga-Carvalho C., Mota J.F., Oyama L.M., Ribeiro E.B., Oller do Nascimento C.M. Effects of adrenal hormones on the expression of adiponectin and adiponectin receptors in adipose tissue, muscle and liver. Steroids 2011, 76:1260-1267.
17. Degawa-Yamauchi M., Moss K.A., Bovenkerk J.E., Shankar S.S., Morrison C.L., Lelliott C.J., et al. Regulation of adiponectin expression in human adipocytes: Effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obesity Research 2005, 13:662-669.
18. Dridi S., Taouis M. Adiponectin and energy homeostasis: Consensus and controversy. The Journal of Nutritional Biochemistry 2009, 20:831-839.
19. Eyster K.M. Dysfunctional hormonal regulation of metabolism in obesity. South Dakota Medicine 2011, 18-21. Spec No:.
20. Fallo F., Scarda A., Sonino N., Paoletta A., Boscaro M., Pagano C., et al. Effect of glucocorticoids on adiponectin: A study in healthy subjects and in Cushing's syndrome. European Journal of Endocrinology 2004, 150:339-344.
21. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2002, 290:1084-1089.
22. Fasshauer M., Kralisch S., Klier M., Lossner U., Bluher M., Klein J., et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2003, 301:1045-1050.
23. Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-1603.
24. Gunn J.M., Hanson R.W., Meyuhas O., Reshef L., Ballard F.J. Glucocorticoids and the regulation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in the rat. The Biochemical Journal 1975, 150:195-203.
25. Halleux C.M., Takahashi M., Delporte M.L., Detry R., Funahashi T., Matsuzawa Y., et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochemical and Biophysical Research Communications 2001, 288:1102-1107.
26. Hasselgren P.O. Glucocorticoids and muscle catabolism. Current Opinion in Clinical Nutrition and Metabolic Care 1999, 2:201-205.
27. Heppner K.M., Habegger K.M., Day J., Pfluger P.T., Perez-Tilve D., Ward B., et al. Glucagon regulation of energy metabolism. Physiology & Behavior 2010, 100:545-548.
28. Hjelmesaeth J., Flyvbjerg A., Jenssen T., Frystyk J., Ueland T., Hagen M., et al. Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: Impact of immunosuppressive and antihypertensive drug therapy. Clinical Journal of the American Society of Nephrology 2006, 1:575-582.
29. Hozumi A., Osaki M., Sakamoto K., Goto H., Fukushima T., Baba H., et al. Dexamethasone-induced plasminogen activator inhibitor-1 expression in human primary bone marrow adipocytes. Biomedical Research 2010, 31:281-286.
30. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003, 52:1655-1663.
31. Iynedjian P.B., Ballard F.J., Hanson R.W. The regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat kidney cortex. The role of acid-base balance and glucocorticoids. The Journal of Biological Chemistry 1975, 250:5596-5603.
32. Jang C., Inder W.J., Obeyesekere V.R., Alford F.P. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clinical Endocrinology 2008, 69:745-750.
33. Jin J.Y., Jusko W.J. Pharmacodynamics of glucose regulation by methylprednisolone. II. Normal rats. Biopharmaceutics & Drug Disposition 2009, 30:35-48.
34. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005, 26:439-451.
35. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology and Metabolism 2004, 89:2548-2556.
36. Kershaw E.E., Morton N.M., Dhillon H., Ramage L., Seckl J.R., Flier J.S. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005, 54:1023-1031.
37. Kreiner F., Galbo H. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scandinavian Journal of Rheumatology 2010, 39:402-408.
38. Krsek M., Silha J.V., Jezkova J., Hana V., Marek J., Weiss V., et al. Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clinical Endocrinology 2004, 60:350-357.
39. Lewandowski K.C., Szosland K., Lewinski A. Short-term dexamethasone administration does not alter serum adiponectin or resistin concentrations in overweight and obese subjects despite an increase in insulin resistance. Clinical Endocrinology 2006, 65:551-552.
40. Libe R., Morpurgo P.S., Cappiello V., Maffini A., Bondioni S., Locatelli M., et al. Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery. Clinical Endocrinology 2005, 62:30-36.
41. Liu M., Liu F. Transcriptional and post-translational regulation of adiponectin. The Biochemical Journal 2010, 425:41-52.
42. Lukens F.D. The pancreas: Insulin and glucagon. Annual Review of Physiology 1959, 21:445-474.
43. MacDougald O.A., Mandrup S. Adipogenesis: Forces that tip the scales. Trends in Endocrinology and Metabolism 2002, 13:5-11.
44. Makimura H., Mizuno T.M., Bergen H., Mobbs C.V. Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. American Journal of Physiology. Endocrinology and Metabolism 2002, 283:E1266-E1271.
45. Mohlig M., Wegewitz U., Osterhoff M., Isken F., Ristow M., Pfeiffer A.F., et al. Insulin decreases human adiponectin plasma levels. Hormone and Metabolic Research 2002, 34:655-658.
46. Morton N.M., Paterson J.M., Masuzaki H., Holmes M.C., Staels B., Fievet C., et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004, 53:931-938.
47. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: New mechanisms for generating tissue-specific actions of glucocorticoids. The Journal of Biological Chemistry 2011, 286:3177-3184.
48. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gomez-Reino J.J., et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2006, 65:1198-1201.
49. Ouchi N., Walsh K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta 2007, 380:24-30.
50. Raff H., Bruder E.D. Adiponectin and resistin in the neonatal rat: Effects of dexamethasone and hypoxia. Endocrine 2006, 29:341-344.
51. Randall D.C. Discovering the role of the adrenal gland in the control of body function. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2004, 287:R1007-R1008.
52. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids-New mechanisms for old drugs. The New England Journal of Medicine 2005, 353:1711-1723.
53. Rieth N., Jollin L., Le Panse B., Lecoq A.M., Arlettaz A., De Ceaurriz J., et al. Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men. European Journal of Applied Physiology 2009, 105:309-313.
54. Ringold G.M., Chapman A.B., Knight D.M., Torti F.M. Hormonal control of adipogenesis. Annals of the New York Academy of Sciences 1986, 478:109-119.
55. Rose A.J., Vegiopoulos A., Herzig S. Role of glucocorticoids and the glucocorticoid receptor in metabolism: Insights from genetic manipulations. The Journal of Steroid Biochemistry and Molecular Biology 2010, 122:10-20.
56. Ryan V.H., German A.J., Wood I.S., Hunter L., Morris P., Trayhurn P. Adipokine expression and secretion by canine adipocytes: Stimulation of inflammatory adipokine production by LPS and TNFalpha. Pflügers Archiv 2010, 460:603-616.
57. Sakamoto K., Osaki M., Hozumi A., Goto H., Fukushima T., Baba H., et al. Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes. BMC Musculoskeletal Disorders 2011, 12:82.
58. Schaaf M.J., Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. The Journal of Steroid Biochemistry and Molecular Biology 2002, 83:37-48.
59. Shi J.H., Du W.H., Liu X.Y., Fan Y.P., Hu X.L., Zhou H.Y., et al. Glucocorticoids decrease serum adiponectin level and WAT adiponectin mRNA expression in rats. Steroids 2010, 75:853-858.
60. Spranger J., Kroke A., Mohlig M., Bergmann M.M., Ristow M., Boeing H., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
61. Stofkova A. Leptin and adiponectin: From energy and metabolic dysbalance to inflammation and autoimmunity. Endocrine Regulations 2009, 43:157-168.
62. Sukumaran S., Almon R.R., DuBois D.C., Jusko W.J. Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. Advanced Drug Delivery Reviews 2010, 62:904-917.
63. Sukumaran S., Jusko W.J., DuBois D.C., Almon R.R. Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression. The Journal of Pharmacology and Experimental Therapeutics 2011, 337:734-746.
64. Swarbrick M.M., Havel P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metabolic Syndrome and Related Disorders 2008, 6:87-102.
65. Swartz S.L., Dluhy R.G. Corticosteroids: Clinical pharmacology and therapeutic use. Drugs 1978, 16:238-255.
66. Tirone T.A., Brunicardi F.C. Overview of glucose regulation. World Journal of Surgery 2001, 25:461-467.
67. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., et al. 11beta-hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response. Endocrine Reviews 2004, 25:831-866.
68. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research 2002, 53:865-871.
69. Uchida H.A., Nakamura Y., Kaihara M., Norii H., Hanayama Y., Sugiyama H., et al. Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy. Nephrology, Dialysis, Transplantation 2006, 21:3475-3480.
70. Vegiopoulos A., Herzig S. Glucocorticoids, metabolism and metabolic diseases. Molecular and Cellular Endocrinology 2007, 275:43-61.
71. Wang P., Mariman E., Renes J., Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. Journal of Cellular Physiology 2008, 216:3-13.
72. Xu A., Wong L.C., Wang Y., Xu J.Y., Cooper G.J., Lam K.S. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Letters 2004, 572:129-134.
73. Yamada T., Oka Y., Katagiri H. Inter-organ metabolic communication involved in energy homeostasis: Potential therapeutic targets for obesity and metabolic syndrome. Pharmacology & Therapeutics 2008, 117:188-198.
74. Yu J.G., Javorschi S., Hevener A.L., Kruszynska Y.T., Norman R.A., Sinha M., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 2002, 51:2968-2974.
75. Ziemke F., Mantzoros C.S. Adiponectin in insulin resistance: Lessons from translational research. The American Journal of Clinical Nutrition 2010, 91:258S-261S.